Together these data suggest that targeting the dysfunctional HSF1-driven HSP chaperone system with PU-H71 significantly reduces oTau-induced pathology and neurodegeneration in AstTau, accentuating the involvement of HSPs in tauopathies. This evidence concerns the gene HSF1 and tauopathy.